Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    A Rare Case of a Large Spinal Meningioma with Mediastinal Extension and Malignant Behavior Classified Histologically as Benign

    Aim: To report a rare case of a spinal WHO grade I meningioma extending through intervertebral foramina C7 to D4 with an extensive mediastinal mass and infiltration of the vertebrae, and to discuss the malignant ...

    S. Dahdal, R. H. Andres, E. Hewer in Theranostics, Gallium-68, and Other Radion… (2013)

  2. No Access

    Chapter and Conference Paper

    Guiding principles applied in the design of GPCR-selective hypothalamic hormone agonists and antagonists

    Strategies for the design of peptide agonists and antagonists of gonadotropin releasing hormone (GnRH, one ligand and one receptor) and of receptor-selective agonists and antagonists of somatostatin (SRIF, thr...

    J. Rivier, J. Gulyas, J. Erchegyi in Insights into Receptor Function and New Dr… (2006)

  3. No Access

    Chapter and Conference Paper

    The Use of Sandostatin® in Insulinomas. The Relation Between In Vivo Responses, the Presence of Somatostatin Receptors and the Development of Tachyphylaxis

    Patients with insulin-secreting islet cell tumors are at risk for severe, protracted hypoglycemia. Surgical removal of the tumor is the treatment of choice. During the diagnostic work up, medical treatment for...

    S. W. J. Lamberts, J.-C. Reubi in Sandostatin® in the Treatment of Gastroent… (1989)

  4. No Access

    Chapter and Conference Paper

    Chemical Structure, Pharmacodynamic Profile and Pharmacokinetics of SMS 201–995 (Sandostatin®)

    Natural somatostatin (SRIF) is a tetra-decapeptide with a multiplicity of inhibiting actions on the secretion of a variety of hormones. In vivo, the compound has a biological half-life of only two to three minute...

    P. Marbach, H. Andres, M. Azria, W. Bauer in Sandostatin® in the Treatment of Acromegaly (1988)